The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Saved in:
| Title: | The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. |
|---|---|
| Authors: | Gasca-Capote C; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Lian X; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Gao C; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Roseto IC; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Jiménez-León MR; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Gladkov G; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Camacho-Sojo MI; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Pérez-Gómez A; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Gallego I; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Lopez-Cortes LE; Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.; Department of Medicine and Microbiology, School of Medicine and.; IBiS, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain., Bachiller S; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.; Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Seville, Spain., Vitalle J; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Rafii-El-Idrissi Benhnia M; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.; Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Seville, Spain., Ostos FJ; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.; Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Seville, Spain., Collado-Romacho AR; Infectious Diseases Unit, Internal Medicine Service, Torrecardenas University Hospital, Almeria, Spain., Santos J; Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Malaga, Spain., Palacios R; Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Malaga, Spain., Gomez-Ayerbe C; Infectious Diseases, Microbiology and Preventive Medicine Unit, Virgen de la Victoria University Hospital, Malaga, Spain., Muñoz-Medina L; Unit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain., Ruiz-Sancho A; Unit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain., Frias M; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Service of Infectious Diseases, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba University, Cordoba, Spain., Rivero-Juarez A; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Service of Infectious Diseases, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba University, Cordoba, Spain., Roca-Oporto C; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Hidalgo-Tenorio C; Unit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain., Rull A; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Joan XXIII University Hospital of Tarragona, IISPV, University of Rovira i Virgili, Tarragona, Spain., Olalla J; Internal Medicine Department, Costa Del Sol Hospital, Marbella, Spain., Lopez-Ruz MA; Unit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, Granada, Spain., Vidal F; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Joan XXIII University Hospital of Tarragona, IISPV, University of Rovira i Virgili, Tarragona, Spain., Viladés C; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Joan XXIII University Hospital of Tarragona, IISPV, University of Rovira i Virgili, Tarragona, Spain., Mastrangelo A; Service of Immunology and Allergy, Lausanne University Hospital and., Cavassini M; Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Espinosa N; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Perreau M; Service of Immunology and Allergy, Lausanne University Hospital and., Peraire J; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Joan XXIII University Hospital of Tarragona, IISPV, University of Rovira i Virgili, Tarragona, Spain., Rivero A; CIBERINFEC, Institute of Health Carlos III (ISCIII), Madrid, Spain.; Service of Infectious Diseases, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba University, Cordoba, Spain., López-Cortes LF; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain., Lichterfeld M; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yu XG; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.; Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ruiz-Mateos E; Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, Spanish National Research Council (CSIC), University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Feb 20; Vol. 134 (8). Date of Electronic Publication: 2024 Feb 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
